Related references
Note: Only part of the references are listed.Histone demethylase JMJD1A in cancer progression and therapeutic resistance
Hee-Young Jeon et al.
MOLECULAR CARCINOGENESIS (2022)
KDM6B interacts with TFDP1 to activate P53 signaling in regulating mouse palatogenesis
Tingwei Guo et al.
ELIFE (2022)
Discovery of Novel Pyrazole-Based KDM5B Inhibitor TK-129 and Its Protective Effects on Myocardial Remodeling and Fibrosis
Kai Tang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
KDM4 inhibitor SD49-7 attenuates leukemia stem cell via KDM4A/MDM2/p21CIPI axis
Yinghui Li et al.
THERANOSTICS (2022)
Design, Synthesis, and Biological Evaluation of Lysine Demethylase 5 C Degraders
Tetsuya Iida et al.
CHEMMEDCHEM (2021)
Discovery of a potent and selective inhibitor of histone lysine demethylase KDM4D
Zhen Fang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
IOX1 Suppresses Wnt Target Gene Transcription and Colorectal Cancer Tumorigenesis through Inhibition of KDM3 Histone Demethylases
Rosalie G. Hoyle et al.
MOLECULAR CANCER THERAPEUTICS (2021)
Modulators of histone demethylase JMJD1C selectively target leukemic stem cells
Yong Yang et al.
FEBS OPEN BIO (2021)
The Dual Function of KDM5C in Both Gene Transcriptional Activation and Repression Promotes Breast Cancer Cell Growth and Tumorigenesis
Hai-feng Shen et al.
ADVANCED SCIENCE (2021)
Crystal structures of two inhibitors in complex with histone lysine demethylase 4D (KDM4D) provide new insights for rational drug design
Tianqi Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
KDM4 Involvement in Breast Cancer and Possible Therapeutic Approaches
Benluvankar Varghese et al.
FRONTIERS IN ONCOLOGY (2021)
Enhanced Properties of a Benzimidazole Benzylpyrazole Lysine Demethylase Inhibitor: Mechanism-of-Action, Binding Site Analysis, and Activity in Cellular Models of Prostate Cancer
David M. Carter et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Deficiency of the X-inactivation escaping gene KDM5C in clear cell renal cell carcinoma promotes tumorigenicity by reprogramming glycogen metabolism and inhibiting ferroptosis
Qian Zheng et al.
THERANOSTICS (2021)
KDM2B promotes IL-6 production and inflammatory responses through Brg1-mediated chromatin remodeling
Qingqing Zhou et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Small molecular modulators of JMJD1C preferentially inhibit growth of leukemia cells
Xin Xu et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Rational design, synthesis and biological profiling of new KDM4C inhibitors
Vatroslav Letfus et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2020)
Discovery of pyrazole derivatives as cellular active inhibitors of histone lysine specific demethylase 5B (KDM5B/JARID1B)
Bing Zhao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Systematic characterization of chromatin modifying enzymes identifies KDM3B as a critical regulator in castration resistant prostate cancer
Hilal Sarac et al.
ONCOGENE (2020)
Catalysis by the Non-Heme Iron(II) Histone Demethylase PHF8 Involves Iron Center Rearrangement and Conformational Modulation of Substrate Orientation
Shobhit S. Chaturvedi et al.
ACS CATALYSIS (2020)
Metalloprotein-Catalyzed Click Reaction for In Situ Generation of a Potent Inhibitor
Yuka Miyake et al.
ACS CATALYSIS (2020)
A New Family of Jumonji C Domain-Containing KDM Inhibitors Inspired by Natural Product Purpurogallin
Jose A. Souto et al.
FRONTIERS IN CHEMISTRY (2020)
Inhibition of Histone H3K27 Demethylases Inactivates Brachyury (TBXT) and Promotes Chordoma Cell Death
Lucia Cottone et al.
CANCER RESEARCH (2020)
Epigenetic Regulation of Wnt Signaling by Carboxamide-Substituted Benzhydryl Amines that Function as Histone Demethylase Inhibitors
Wen Zhang et al.
ISCIENCE (2020)
Identification of novel lysine demethylase 5-selective inhibitors by inhibitorbased fragment merging strategy
Yuka Miyake et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
Biology and targeting of the Jumonji-domain histone demethylase family in childhood neoplasia: a preclinical overview
Tyler S. McCann et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2019)
KDM4B is a coactivator of c-Jun and involved in gastric carcinogenesis
Meng-Chen Wu et al.
CELL DEATH & DISEASE (2019)
The Clinically Used Iron Chelator Deferasirox Is an Inhibitor of Epigenetic JumonjiC Domain-Containing Histone Demethylases
Martin Roatsch et al.
ACS CHEMICAL BIOLOGY (2019)
The roles of DNA, RNA and histone methylation in ageing and cancer
Ewa M. Michalak et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Structure-Based Screening of Tetrazolylhydrazide Inhibitors versus KDM4 Histone Demethylases
Piotr H. Malecki et al.
CHEMMEDCHEM (2019)
Epigenetic Regulation of Adipogenic Differentiation by Histone Lysine Demethylation
Geovanny Nic-Can et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Benzo[b]tellurophenes as a Potential Histone H3 Lysine 9 Demethylase (KDM4) Inhibitor
Yoon-Jung Kim et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Design, Synthesis and Characterization of Covalent KDM5 Inhibitors
Saleta Vazquez-Rodriguez et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Histone demethylase KDM6B has an anti-tumorigenic function in neuroblastoma by promoting differentiation
Liqun Yang et al.
ONCOGENESIS (2019)
Structure-Based Discovery of a Selective KDM5A Inhibitor that Exhibits Anti-Cancer Activity via Inducing Cell Cycle Arrest and Senescence in Breast Cancer Cell Lines
Guan-Jun Yang et al.
CANCERS (2019)
Pathogenic and Therapeutic Role of H3K4 Family of Methylases and Demethylases in Cancers
Aman Kumar et al.
INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY (2019)
Imidazopyridines as Potent KDM5 Demethylase Inhibitors Promoting Reprogramming Efficiency of Human iPSCs
Yasamin Dabiri et al.
ISCIENCE (2019)
Two-domain analysis of JmjN-JmjC and PHD-JmjC lysine demethylases: Detecting an inter-domain evolutionary stress
Patrick Slama
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2018)
Selective Inhibition of Lysine-Specific Demethylase 5A (KDM5A) Using a Rhodium(III) Complex for Triple-Negative Breast Cancer Therapy
Guan-Jun Yang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
Structure-based design and discovery of potent and selective KDM5 inhibitors
Zhe Nie et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Loss of KDM6A Activates Super-Enhancers to Induce Gender-Specific Squamous-like Pancreatic Cancer and Confers Sensitivity to BET Inhibitors
Jaclyn Andricovich et al.
CANCER CELL (2018)
H3K9 demethylase KDM4E is an epigenetic regulator for bovine embryonic development and a defective factor for nuclear reprogramming
Xin Liu et al.
DEVELOPMENT (2018)
UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs
Malgorzata Gozdecka et al.
NATURE GENETICS (2018)
JMJD2B/KDM4B inactivation in adipose tissues accelerates obesity and systemic metabolic abnormalities
Changkeun Kang et al.
GENES TO CELLS (2018)
Histone demethylase KDM7A controls androgen receptor activity and tumor growth in prostate cancer
Kyoung-Hwa Lee et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Rhodium(III)-Based Inhibitor of the JMJD3-H3K27me3 Interaction and Modulator of the Inflammatory Response
Tian-Shu Kang et al.
INORGANIC CHEMISTRY (2018)
Structure-Based Engineering of Irreversible Inhibitors against Histone Lysine Demethylase KDM5A
John R. Horton et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Mechanisms of NF-kappa B p65 and strategies for therapeutic manipulation
Sivagami Giridharan et al.
JOURNAL OF INFLAMMATION RESEARCH (2018)
Identification and characterization of PKF118-310 as a KDM4A inhibitor
Gianluigi Franci et al.
EPIGENETICS (2017)
Novel inhibitors of lysine (K)-specific Demethylase 4A with anticancer activity
Hyo Jeong Lee et al.
INVESTIGATIONAL NEW DRUGS (2017)
KDM3 epigenetically controls tumorigenic potentials of human colorectal cancer stem cells through Wnt/β-catenin signalling
Jiong Li et al.
NATURE COMMUNICATIONS (2017)
The histone demethylase KDM3A regulates the transcriptional program of the androgen receptor in prostate cancer cells
Stephen Wilson et al.
ONCOTARGET (2017)
Lysine demethylase KDM2A inhibits TET2 to promote DNA methylation and silencing of tumor suppressor genes in breast cancer
J-Y Chen et al.
ONCOGENESIS (2017)
Identification of a Novel Benzimidazole Pyrazolone Scaffold That Inhibits KDM4 Lysine Demethylases and Reduces Proliferation of Prostate Cancer Cells
David M. Carter et al.
SLAS DISCOVERY (2017)
Discovery of a Highly Selective Cell-Active Inhibitor of the Histone Lysine Demethylases KDM2/7
Philip A. Gerken et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Discovery of pyrazolo[1,5-a]pyrimidine-3-carbonitrile derivatives as a new class of histone lysine demethylase 4D (KDM4D) inhibitors
Zhen Fang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
From a novel HTS hit to potent, selective, and orally bioavailable KDM5 inhibitors
Jun Liang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Potent and Selective KDM5 Inhibitor Stops Cellular Demethylation of H3K4me3 at Transcription Start Sites and Proliferation of MM1S Myeloma Cells
Anthony Tumber et al.
CELL CHEMICAL BIOLOGY (2017)
Advances and challenges in understanding histone demethylase biology
Radoslaw P. Nowak et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2016)
Jumonji histone demethylases as emerging therapeutic targets
Sung Yeon Park et al.
PHARMACOLOGICAL RESEARCH (2016)
Protein arginine methylation/demethylation and cancer
Coralie Poulard et al.
ONCOTARGET (2016)
KDM4C and ATF4 Cooperate in Transcriptional Control of Amino Acid Metabolism
Erhu Zhao et al.
CELL REPORTS (2016)
Hypoxia-Inducible Histone Lysine Demethylases: Impact on the Aging Process and Age-Related Diseases
Antero Salminen et al.
AGING AND DISEASE (2016)
Structural definitions of Jumonji family demethylase selectivity
Ewa S. Pilke et al.
DRUG DISCOVERY TODAY (2015)
Histone demethylases in chromatin biology and beyond
Emilia Dimitrova et al.
EMBO REPORTS (2015)
The role dietary of bioactive compounds on the regulation of histone acetylases and deacetylases: A review
F. Vahid et al.
GENE (2015)
Targeting histone lysine methylation in cancer
John McGrath et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Epigenetic regulation by histone demethylases in hypoxia
Rebecca L. Hancock et al.
EPIGENOMICS (2015)
Identification of a novel actin-dependent signal transducing module allows for the targeted degradation of GLI1
Philipp Schneider et al.
NATURE COMMUNICATIONS (2015)
Studies on the catalytic domains of multiple JmjC oxygenases using peptide substrates
Sophie T. Williams et al.
EPIGENETICS (2014)
KDM5C mutational screening among males with intellectual disability suggestive of X-Linked inheritance and review of the literature
Thaina Fernandez Goncalves et al.
EUROPEAN JOURNAL OF MEDICAL GENETICS (2014)
KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling
Klaus W. Wagner et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Histone lysine demethylases as targets for anticancer therapy
Jonas W. Hojfeldt et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
PHF8 activates transcription of rRNA genes through H3K4me3 binding and H3K9me1/2 demethylation
Weijun Feng et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development
Karl Agger et al.
NATURE (2007)
Structural basis of the recognition of a methylated histone tail by JMJD2A
Zhongzhou Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Recognition of histone H3 lysine-4 methylation by the double tudor domain of JMJD2A
Y Huang et al.
SCIENCE (2006)
Structural studies on 2-oxoglutarate oxygenases and related double-stranded β-helix fold proteins
Ian J. Clifton et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2006)
TPR proteins: the versatile helix
LD D'Andrea et al.
TRENDS IN BIOCHEMICAL SCIENCES (2003)
Gene targeting of desrt, a novel ARID class DNA-binding protein, causes growth retardation and abnormal development of reproductive organs
MH Lahoud et al.
GENOME RESEARCH (2001)
Regulation of chromatin structure by site-specific histone H3 methyltransferases
S Rea et al.
NATURE (2000)